The present invention relates to a dendrite elongation inhibitor for melanocytes consisting of a compound represented by the following general formula (1): and/or a salt thereof, wherein R1, R2, R3, R4, R5, and R6 each independently represent a hydrogen atom or a C1-4 alkyl group, and a skin preparation for external use comprising the dendrite elongation inhibitor for melanocytes as an active ingredient.
